tiprankstipranks
Trending News
More News >
Nordson Corp (NDSN)
NASDAQ:NDSN

Nordson (NDSN) AI Stock Analysis

Compare
362 Followers

Top Page

NDSN

Nordson

(NASDAQ:NDSN)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 4o)
Rating:79Outperform
Price Target:
$272.00
▲(14.25% Upside)
Nordson's strong financial performance and positive earnings call guidance are the most significant factors driving the score. Technical analysis supports a moderate bullish outlook, while valuation suggests the stock is priced at a premium. The company's strategic initiatives and robust cash flow further bolster its position, despite some challenges in specific segments.
Positive Factors
Strong Cash Flow Generation
Robust cash flow supports strategic initiatives like share repurchases and debt reduction, enhancing financial flexibility and shareholder value.
Successful Integration of Atrion Medical
Successful integration of acquisitions like Atrion Medical can drive revenue and earnings growth, strengthening market position and operational capabilities.
Record EBITDA and Margin
High EBITDA and margins indicate efficient operations and strong profitability, supporting sustainable growth and competitive advantage.
Negative Factors
Organic Sales Decline
Declining organic sales suggest challenges in maintaining growth momentum, potentially impacting future revenue and market share.
High Debt Levels
High debt levels can strain financial resources, limiting flexibility and increasing risk, especially in volatile market conditions.
Weakness in Advanced Technology Solutions
Weakness in key segments like advanced technology solutions may hinder growth prospects and affect overall business performance.

Nordson (NDSN) vs. SPDR S&P 500 ETF (SPY)

Nordson Business Overview & Revenue Model

Company DescriptionNordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids worldwide. It operates through two segments, Industrial Precision Solutions (IPS) and Advanced Technology Solutions (ATS). The IPS segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems used in packaged goods industries; components and systems used in the thermoplastic melt stream; and product assembly systems for use in paper and paperboard converting applications, and manufacturing roll goods, as well as for the assembly of plastic, metal, and wood products. It also offers automated and manual dispensing products and systems to apply adhesive and sealant materials; dispensing and curing systems to coat and cure containers; systems to apply liquid paints and coatings to consumer and industrial products; and systems to apply powder paints and coatings to metal, plastic, and wood products, as well as ultraviolet equipment for use in curing and drying operations for specialty coatings, semiconductor materials, and paints. The ATS segment provides automated dispensing systems for the attachment, protection, and coating of fluids, as well as related gas plasma treatment systems for cleaning and conditioning surfaces; precision manual and semi-automated dispensers, minimally invasive interventional delivery devices, plastic molded syringes, cartridges, tips, fluid connection components, tubing, balloons, and catheters; and bond testing and automated optical, acoustic microscopy, and x-ray inspection systems for use in semiconductor and printed circuit board industries. The company markets its products through direct sales force, as well as distributors and sales representatives. Nordson Corporation was founded in 1935 and is headquartered in Westlake, Ohio.
How the Company Makes MoneyNordson generates revenue primarily through the sale of its advanced equipment and systems, which are utilized in a wide range of industrial applications. Key revenue streams include the sale of dispensing equipment, surface treatment solutions, and other manufacturing technologies. The company also earns income from service contracts and aftermarket parts, which provide ongoing support and maintenance for its products. Significant partnerships with leading companies in various industries enhance Nordson's market reach and foster innovation, while its focus on R&D helps in developing new technologies that meet evolving customer needs. Additionally, Nordson's global presence allows it to tap into diverse markets, contributing to its overall revenue growth.

Nordson Key Performance Indicators (KPIs)

Any
Any
Sales by Segment
Sales by Segment
Chart Insights
Data provided by:The Fly

Nordson Earnings Call Summary

Earnings Call Date:Dec 10, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Feb 25, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mix of positive financial achievements and growth in certain segments, alongside challenges in organic sales and specific product lines. The company demonstrated strong cash flow and operational performance, but faced headwinds in some areas.
Q4-2025 Updates
Positive Updates
Record EBITDA and Cash Flow
Achieved record EBITDA of $256 million, expanding EBITDA margin to 34% in the quarter. Generated record cash flow of $194 million with a conversion rate to net income of 128%.
Fiscal Year 2025 Financial Performance
Record sales of $2.8 billion, up 4% from last year, and record adjusted earnings per share of $10.24, exceeding the midpoint of initial full-year guidance.
Successful Integration of Atrion Medical
The integration of Atrion Medical was successful and contributed to sales and EPS growth in its first year.
Strong Free Cash Flow Generation
Full-year free cash flow conversion of 136% of net income, enabling $300 million share repurchase, increased dividends, and reduced net debt.
Medical and Fluid Solutions Segment Growth
Sales increased by 10%, with organic sales volume up 7%, EBITDA margin improved from 36% to 40%.
Negative Updates
Organic Sales Decline
Organic sales decreased by 1% in the fourth quarter and were down roughly 3% for the full year, driven by softness in selected industrial and advanced technology systems.
Weakness in Advanced Technology Solutions
Sales decreased by 4% compared to the prior year's fourth quarter, driven by weakness in x-ray systems demand.
Industrial Precision Solutions Decline
Sales decreased by 2%, with year-over-year declines in polymer processing product lines and smaller reductions in industrial coating systems.
Company Guidance
During Nordson Corporation's fourth-quarter and full-year 2025 conference call, the company provided robust guidance for fiscal 2026, projecting full-year sales growth between 1% and 6% over 2025's record $2.8 billion. Adjusted earnings per share are forecasted to increase by 6% to 12%, with a midpoint of 9%. The company anticipates a strong start in the first quarter, with sales expected to range from $630 million to $670 million and adjusted earnings per share between $2.25 and $2.45. Nordson highlighted its record EBITDA of $900 million, maintaining an EBITDA margin of 32%. Additionally, the company achieved a free cash flow conversion rate of 136% of net income, enabling $300 million in share repurchases and a leverage ratio reduction to 2.1x. The guidance reflects Nordson's optimism in its Industrial Precision Solutions and Medical and Fluid Solutions segments, bolstered by stabilized polymer processing and automotive markets and continued strength in semiconductor applications.

Nordson Financial Statement Overview

Summary
Nordson exhibits strong financial health with consistent revenue and profit growth, efficient operations, and effective cash management. The balance sheet is solid, though high debt levels require monitoring. Overall, the company is well-managed with potential for continued growth despite some leverage and cost pressure risks.
Income Statement
85
Very Positive
Nordson's income statement reflects strong profitability with consistent gross and net profit margins over the years. The company has demonstrated solid revenue growth, particularly in the most recent year with a 26.4% increase. EBIT and EBITDA margins are healthy, indicating efficient operations. However, the slight decline in gross profit margin over the years suggests potential cost pressures.
Balance Sheet
78
Positive
The balance sheet shows a moderate debt-to-equity ratio, which has improved from previous years, indicating better leverage management. Return on equity remains strong, reflecting effective use of shareholder funds. The equity ratio is stable, suggesting a solid financial foundation. However, the total debt level is relatively high, which could pose risks if not managed carefully.
Cash Flow
82
Very Positive
Nordson's cash flow statement highlights robust free cash flow growth in the latest year, recovering from a decline in the previous period. The operating cash flow to net income ratio is close to 1, indicating good cash conversion from profits. The free cash flow to net income ratio is also strong, suggesting efficient cash management. Nonetheless, fluctuations in free cash flow growth rates indicate potential volatility.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.79B2.69B2.63B2.59B2.36B
Gross Profit1.54B1.49B1.43B1.43B1.32B
EBITDA711.73M810.58M786.74M771.62M703.55M
Net Income484.47M467.28M487.49M513.10M454.37M
Balance Sheet
Total Assets5.06B6.00B5.25B3.82B3.79B
Cash, Cash Equivalents and Short-Term Investments108.44M115.95M115.68M163.46M299.97M
Total Debt2.00B2.32B1.86B860.45M951.55M
Total Liabilities2.87B3.07B2.65B1.53B1.63B
Stockholders Equity3.04B2.93B2.60B2.29B2.16B
Cash Flow
Free Cash Flow661.12M491.78M606.70M461.70M507.62M
Operating Cash Flow719.17M556.19M641.28M513.13M545.93M
Investing Cash Flow-26.69M-844.40M-1.44B-222.76M-33.17M
Financing Cash Flow-706.43M294.50M750.51M-416.01M-422.91M

Nordson Technical Analysis

Technical Analysis Sentiment
Positive
Last Price238.07
Price Trends
50DMA
233.18
Positive
100DMA
226.97
Positive
200DMA
214.64
Positive
Market Momentum
MACD
1.16
Negative
RSI
57.62
Neutral
STOCH
27.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NDSN, the sentiment is Positive. The current price of 238.07 is above the 20-day moving average (MA) of 234.72, above the 50-day MA of 233.18, and above the 200-day MA of 214.64, indicating a bullish trend. The MACD of 1.16 indicates Negative momentum. The RSI at 57.62 is Neutral, neither overbought nor oversold. The STOCH value of 27.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NDSN.

Nordson Risk Analysis

Nordson disclosed 25 risk factors in its most recent earnings report. Nordson reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Nordson Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$13.28B27.7816.21%1.67%3.78%4.85%
78
Outperform
$13.71B28.2719.45%1.32%2.85%3.09%
75
Outperform
$13.26B28.0112.21%1.60%7.09%-2.29%
72
Outperform
$15.06B29.0917.85%0.82%8.01%2.67%
71
Outperform
$10.80B33.8918.09%0.50%-0.37%21.77%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
59
Neutral
$9.12B27.5612.38%5.52%9.03%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NDSN
Nordson
238.07
32.91
16.04%
GNRC
Generac Holdings
144.82
-11.30
-7.24%
GGG
Graco
83.16
-0.48
-0.57%
IEX
IDEX
176.33
-30.79
-14.87%
ITT
ITT
172.08
30.80
21.80%
CR
Crane Company
183.83
32.09
21.15%

Nordson Corporate Events

Business Operations and StrategyFinancial Disclosures
Nordson Reports Record Q4 and Fiscal 2025 Results
Positive
Dec 10, 2025

Nordson Corporation reported record results for the fourth quarter and fiscal year 2025, with sales reaching $752 million in the fourth quarter and $2.8 billion for the full year, marking a 1% and 4% increase respectively over the prior year. The company achieved a 9% increase in adjusted earnings per share for the fourth quarter and a 5% increase for the full year, reflecting strong operational performance despite challenges such as the divestiture of its medical contract manufacturing business. Looking ahead to fiscal 2026, Nordson forecasts sales between $2,830 to $2,950 million and adjusted earnings per share ranging from $10.80 to $11.50, driven by its strategic growth framework and strong backlog.

Executive/Board ChangesBusiness Operations and Strategy
Nordson Approves New Executive Severance Policy
Neutral
Oct 28, 2025

On October 23, 2025, Nordson Corporation’s Board of Directors approved a new Executive Severance Policy, effective November 1, 2025, to provide severance protections for U.S.-based executive officers in case of employment termination outside a change in control period. This policy outlines conditions under which executives can receive severance benefits, including a lump-sum payment and continued medical coverage, impacting the company’s operations by potentially enhancing executive retention and stability.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025